Table 1.
Compound | ANOVA | Time (min) | Dose (mg/kg) | N | HTR Counts (Mean ± SEM) | ED50 mg/kg (95% CI) | ED50 μmol/kg (95% CI) |
---|---|---|---|---|---|---|---|
DOMa | F(5,23)=17.1, p<0.0001 | 30 | 0 | 5 | 4.6 ± 0.9 | 0.43 (0.30–0.62) | 1.75 (1.22–2.52) |
0.1 | 5 | 17.4 ± 1.7 | |||||
0.3 | 5 | 52.6 ± 8.0 | |||||
1 | 5 | 118.0 ± 14.5 ** | |||||
3 | 5 | 126.8 ± 24.4 ** | |||||
10 | 4 | 27.0 ± 8.6 | |||||
| |||||||
DOETa | F(4,22)=7.68, p=0.0005 | 30 | 0 | 6 | 7.5 ± 1.7 | 0.20 (0.11–0.36) | 0.77 (0.43–1.37) |
0.1 | 5 | 34.8 ± 8.7 | |||||
0.3 | 5 | 86.2 ± 9.6 * | |||||
1 | 6 | 122.0 ± 29.3 ** | |||||
3 | 5 | 71.0 ± 14.2 * | |||||
| |||||||
DOBUc | F(4,26)=36.68, p<0.0001 | 30 | 0 | 7 | 6.6 ± 1.9 | 1.17 (0.99–1.38) | 4.64 (3.92–5.50) |
0.3 | 6 | 13.0 ± 2.5 | |||||
1 | 6 | 46.3 ± 6.3 ** | |||||
3 | 6 | 111.8 ± 12.4 ** | |||||
10 | 6 | 25.5 ± 7.7 | |||||
| |||||||
DOCa | F(3,18)=23.92, p<0.0001 | 30 | 0 | 6 | 8.2 ± 1.4 | 0.32 (0.21–0.47) | 1.19 (0.80–1.77) |
0.3 | 5 | 64.0 ± 2.0 ** | |||||
1 | 6 | 125.3 ± 13.5 ** | |||||
3 | 5 | 89.8 ± 16.3 ** | |||||
| |||||||
R-(-)-DOIa | F(4,23)=25.14, p<0.0001 | 30 | 0 | 7 | 9.4 ± 1.7 | 0.24 (0.17–0.33) | 0.66 (0.47–0.93) |
0.1 | 5 | 27.2 ± 3.1 | |||||
0.3 | 6 | 89.2 ± 12.0 ** | |||||
1 | 5 | 132.0 ± 17.0 ** | |||||
3 | 5 | 97.0 ± 12.8 ** | |||||
| |||||||
DONa | F(4,20)=7.65, p=0.0007 | 30 | 0 | 5 | 6.4 ± 2.3 | 1.31 (0.70–2.43) | 4.72 (2.54–8.77) |
0.3 | 5 | 17.4 ± 3.4 | |||||
1 | 5 | 43.0 ± 1.2 | |||||
3 | 5 | 102.8 ± 6.9 ** | |||||
10 | 5 | 96.2 ± 34.9 ** | |||||
| |||||||
MDAa | F(4,22)=3.53, p=0.0227 | 30 | 0 | 6 | 6.2 ± 1.4 | 1.46 (0.72–2.98) | 6.77 (3.33–13.8) |
0.3 | 5 | 6.6 ± 1.2 | |||||
1 | 5 | 9.6 ± 1.1 | |||||
3 | 6 | 16.7 ± 2.4 * | |||||
10 | 5 | 15.0 ± 5.1 | |||||
| |||||||
R-(-)-MDAa | F(4,23)=8.11, P=0.0003 | 30 | 0 | 6 | 7.8 ± 1.4 | 1.45 (0.82–2.54) | 6.71 (3.82–11.8) |
0.3 | 5 | 8.6 ± 1.5 | |||||
1 | 6 | 15.5 ± 3.2 | |||||
3 | 6 | 30.0 ± 6.2 ** | |||||
10 | 5 | 27.6 ± 2.8 ** | |||||
| |||||||
α-Et-2C-Da | F(4,23)=3.95, P=0.0139 | 30 | 0 | 5 | 9.4 ± 2.6 | 4.09 (2.70–6.22) | 15.8 (10.4–23.9) |
3 | 6 | 14.2 ± 4.1 | |||||
6 | 5 | 25.4 ± 4.9 * | |||||
12 | 6 | 26.0 ± 2.2 * | |||||
24 | 6 | 14.5 ± 4.0 | |||||
| |||||||
25D-NBOMea | F(5,28)=10.57, P<0.0001 | 30 | 0 | 6 | 6.2 ± 0.8 | 0.23 (0.12–0.43) | 0.64 (0.34–1.22) |
0.03 | 5 | 12.2 ± 2.9 | |||||
0.1 | 6 | 39.2 ± 7.5 | |||||
0.3 | 6 | 45.0 ± 12.5 | |||||
1 | 6 | 96.7 ± 17.2 ** | |||||
3 | 5 | 85.6 ± 18.9 ** | |||||
| |||||||
25I-NBOHa | F(5,24)=8.90, P<0.0001 | 30 | 0 | 5 | 4.4 ± 1.4 | 0.085 (0.055–0.132) | 0.19 (0.12–0.29) |
0.03 | 5 | 22.8 ± 3.1 | |||||
0.1 | 5 | 48.8 ± 4.7 * | |||||
0.3 | 5 | 95.6 ± 14.2 ** | |||||
1 | 5 | 64.0 ± 12.6 ** | |||||
3 | 5 | 44.4 ± 17.0 | |||||
| |||||||
5-MeO-AMTa | F(4,22)=10.65, p<0.0001 | 30 | 0 | 6 | 4.3 ± 0.8 | 0.53 (0.25–1.11) | 2.21 (1.06–4.60) |
0.1 | 5 | 9.4 ± 2.8 | |||||
0.3 | 5 | 11.0 ± 3.0 | |||||
1 | 6 | 45.0 ± 11.4 ** | |||||
3 | 5 | 50.4 ± 7.4 ** | |||||
| |||||||
DMTb | F(4,21)=41.25, p<0.0001 | 30 | 0 | 6 | 6.5 ± 2.4 | 1.54 (1.08–2.19) | 5.05 (3.55–7.19) |
0.3 | 5 | 11.4 ± 1.8 | |||||
1 | 5 | 25.2 ± 3.5 * | |||||
3 | 5 | 65.6 ± 8.6 ** | |||||
10 | 5 | 76.4 ± 6.2 ** | |||||
| |||||||
DETb | F(5,25)=6.20, p=0.0007 | 20 | 0 | 6 | 3.5 ± 0.5 | 2.28 (1.57–3.30) | 6.85 (4.72–9.93) |
0.625 | 5 | 4.0 ± 1.5 | |||||
1.25 | 5 | 4.6 ± 1.9 | |||||
2.5 | 5 | 13.0 ± 3.6 * | |||||
5 | 5 | 18.8 ± 3.0 ** | |||||
10 | 5 | 13.0 ± 3.7 * | |||||
| |||||||
DPTa | F(4,20)=4.02, p=0.0150 | 20 | 0 | 5 | 4.4 ± 0.5 | 1.90 (1.14–3.19) | 6.78 (4.04–11.4) |
0.625 | 5 | 6.4 ± 1.5 | |||||
1.25 | 5 | 7.8 ± 2.7 | |||||
2.5 | 5 | 26.2 ± 7.1 * | |||||
5 | 5 | 24.8 ± 9.0 * | |||||
| |||||||
DIPTa | F(4,22)=8.9, p=0.0002 | 30 | 0 | 6 | 6.0 ± 0.4 | 2.40 (1.67–3.44) | 8.54 (5.96–12.2) |
1.25 | 5 | 16.6 ± 4.3 | |||||
2.5 | 5 | 27.6 ± 7.1 | |||||
5 | 6 | 53.5 ± 5.3 ** | |||||
10 | 5 | 40.8 ± 12.0 ** |
p < 0.05
p < 0.01, significant difference from the vehicle control group (Dunnett’s test).
Hydrochloride salt
fumarate salt
freebase.